NCT06220825 PRactice of VENTilation in Critically Ill PEDiatric Patients
| NCT ID | NCT06220825 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Medical Center Groningen |
| Condition | Critical Illness |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,500 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2034-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,500 participants in total. It began in 2024-04-01 with a primary completion date of 2034-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this worldwide observational study is to investigate ventilation practice in critically ill pediatric patients. The main questions it aims to answer are: 1. What is the global current practice of ventilatory support in critically ill pediatric patients? 2. Which potentially modifiable factors related to ventilation are associated with outcome? Participating pediatric intensive care units will gather detailed information about ventilation practice and outcome, such as duration of ventilatory support, length of ICU stay and ICU mortality.
Eligibility Criteria
Inclusion Criteria: * Expected use of (non-)invasive respiratory support for at least 12 hrs Exclusion Criteria: * premature infants (i.e., postconceptional age corrected for gestational age \< 40 weeks)
Contact & Investigator
Martin CJ Kneyber, MD PhD
PRINCIPAL INVESTIGATOR
University Medical Center Groningen
Frequently Asked Questions
Who can join the NCT06220825 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Critical Illness. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06220825 currently recruiting?
Yes, NCT06220825 is actively recruiting participants. Contact the research team at r.vanvliet@amsterdamumc.nl for enrollment information.
Where is the NCT06220825 trial being conducted?
This trial is being conducted at Groningen, Netherlands.
Who is sponsoring the NCT06220825 clinical trial?
NCT06220825 is sponsored by University Medical Center Groningen. The principal investigator is Martin CJ Kneyber, MD PhD at University Medical Center Groningen. The trial plans to enroll 2,500 participants.